Dr. Valkal K Bhatt is a pharmacist who is specialized in Oncology in New York, New York. Patients can reach him at 475 Main St, Apartment 13n, New York or contact him on 631-836-9655. Active license number of Dr. Valkal K Bhatt is 054078 for Oncology in New York. Dr. Valkal K Bhatt is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Dr. Valkal K Bhatt speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Valkal K Bhatt
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Male
Location:
475 Main St, Apartment 13n, New York, New York, 10044-0085
Phone:
631-836-9655
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Valkal K Bhatt are as mentioned below.
NPI Number:
1831419845
NPI Enumeration Date:
02 Jun, 2010
NPI Last Update On:
02 Jun, 2010
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Valkal K Bhatt are as mentioned below.
Specialization
License Number
State
Status
Oncology
054078
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
475 Main St, Apartment 13n New York, New York
Zip:
10044-0085
Phone Number:
--
Fax Number:
--
Patients can reach Dr. Valkal K Bhatt at 475 Main St, Apartment 13n, New York, New York or can call on phone at 631-836-9655.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.